Atea Pharmaceuticals Inc (AVIR) — Capital Reinvestment Ratio
Atea Pharmaceuticals Inc (AVIR) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow ($22.60 Million) in capital expenditures ($4.00K). Check how tangible is Atea Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Atea Pharmaceuticals Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Atea Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see AVIR cash flow metrics.
Annual Capital Reinvestment Ratio for Atea Pharmaceuticals Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Atea Pharmaceuticals Inc from 2020 to 2020. See AVIR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $296.73 Million | $26.00K | — |